MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells

por CAO, MENGRU, SEIKE, MASAHIRO, SOENO, CHIE, MIZUTANI, HIDEAKI, KITAMURA, KAZUHIRO, MINEGISHI, YUJI, NORO, RINTARO, YOSHIMURA, AKINOBU, CAI, LI, GEMMA, AKIHIKO
Publicado 2012

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation

por Noro, Rintaro, Gemma, Akihiko, Kosaihira, Seiji, Kokubo, Yutaka, Chen, Mingwei, Seike, Masahiro, Kataoka, Kiyoko, Matsuda, Kuniko, Okano, Tetsuya, Minegishi, Yuji, Yoshimura, Akinobu, Kudoh, Shoji
Publicado 2006

MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation

por Noro, Rintaro, Seike, Masahiro, Zou, Fenfei, Soeno, Chie, Matsuda, Kuniko, Sugano, Teppei, Nishijima, Nobuhiko, Matsumoto, Masaru, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Yoshimura, Akinobu, Kubota, Kaoru, Gemma, Akihiko
Publicado 2015

Glasgow Prognostic Score predicts chemotherapy‐triggered acute exacerbation‐interstitial lung disease in patients with non‐small cell lung cancer

por Kikuchi, Ryota, Takoi, Hiroyuki, Tsuji, Takao, Nagatomo, Yoko, Tanaka, Akane, Kinoshita, Hayato, Ono, Mariko, Ishiwari, Mayuko, Toriyama, Kazutoshi, Kono, Yuta, Togashi, Yuki, Yamaguchi, Kazuhiro, Yoshimura, Akinobu, Abe, Shinji
Publicado 2021

Glasgow prognostic score for prediction of chemotherapy‐triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer

por Kikuchi, Ryota, Takoi, Hiroyuki, Tsuji, Takao, Nagatomo, Yoko, Tanaka, Akane, Kinoshita, Hayato, Ono, Mariko, Ishiwari, Mayuko, Toriyama, Kazutoshi, Kono, Yuta, Togashi, Yuki, Yamaguchi, Kazuhiro, Yoshimura, Akinobu, Abe, Shinji
Publicado 2021

Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre...

por Hirata, Taiki, Kawaguchi, Takashi, Azuma, Kanako, Torii, Ayako, Usui, Hiroaki, Kim, Soan, Hayama, Tatsuya, Hirate, Daisuke, Kawahara, Yosuke, Kumihashi, Yuki, Chisaka, Tomomi, Wako, Tetsuya, Yoshimura, Akinobu, Miyaji, Tempei, Yamaguchi, Takuhiro
Publicado 2023

Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database

por Gemma, Akihiko, Li, Cai, Sugiyama, Yuka, Matsuda, Kuniko, Seike, Yoko, Kosaihira, Seiji, Minegishi, Yuji, Noro, Rintaro, Nara, Michiya, Seike, Masahiro, Yoshimura, Akinobu, Shionoya, Aki, Kawakami, Akiko, Ogawa, Naoki, Uesaka, Haruka, Kudoh, Shoji
Publicado 2006

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

por Miyanaga, Akihiko, Shimizu, Kumi, Noro, Rintaro, Seike, Masahiro, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Shukuya, Takehito, Yoshimura, Akinobu, Kawamoto, Masashi, Tsuchiya, Shinichi, Hagiwara, Koichi, Soda, Manabu, Takeuchi, Kengo, Yamamoto, Nobuyuki, Mano, Hiroyuki, Ishikawa, Yuichi, Gemma, Akihiko
Publicado 2013